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Conclusions: Inhibition of IL-6 in IL-1β stimulated chondrocytes
resulted in reduced mRNA expression of pro-inﬂammatory cy-
tokines and cartilage-degrading enzymes. This indicates the
involvement of IL-6 in catabolic regulation in chondrocytes.
However, blocking IL-6 seemed to also affect the anabolic re-
sponses in chondroctyes. Decreased expression of key cartilage
molecules in response to anabolic treatments suggests a protec-
tive role for IL-6 in the chondrocyte. Our data provide evidence
suggesting that the cytokine, IL-6, could also have beneﬁcial
effects and could contribute to promoting cartilage repair pro-
cesses. Therefore, it will be crucial to monitor patients receiving
IL-6 blocking treatment closely for their joint health.
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ADIPOKINES AND OSTEOARTHRITIS: SYNERGISTIC
EFFECTS OF LEPTIN, FATTY ACIDS AND
INTERLEUKIN-1 ON PROTEOGLYCAN BREAKDOWN
T.M. Grifﬁn, B. Fermor, F. Guilak
Duke University Medical Center, Durham, NC
Purpose: Obesity increases the risk of developing osteoarthri-
tis (OA) in both load-bearing and non-load-bearing joints. This
suggests that a systemic factor is involved, which is potentially
mediated by body fat itself. Obesity elevates circulating free fatty
acid (FA) levels, and OA is associated with increased intra-
articular FA content. Furthermore, adipose tissue is an active
endocrine organ that secretes numerous signaling molecules
(i.e., adipokines). One adipokine in particular, leptin, is associ-
ated with OA and acts synergistically with interleukin-1 (IL-1)
to increase inﬂammation in chondrocytes. We hypothesized that
leptin would function synergistically with IL-1 to increase gly-
cosaminoglycan (GAG) breakdown and nitric oxide production in
articular cartilage explants. We also investigated how elevated
fatty acids inﬂuence these effects.
Methods: Articular cartilage explants were harvested from the
femoral condyles of skeletally mature pigs. Explants were al-
lowed to stabilize in culture medium with 10% FBS for 72 h at
37 degrees C. Media were then replaced with either 0, 1, 10, or
100 ng/ml recombinant human leptin (BACHEM) with or without
the following treatments, for 48 hrs: a) 0.5 mM FA (1:1 oleic
and palmitic acids; SIGMA), b) 0.1 ng/ml recombinant porcine
IL-1alpha (R&D Systems), or c) a combination of 0.5 mM FA +
0.1 ng/ml IL-1alpha. Total sulfated (S)-GAG release into the me-
dia was measured using the 1,9-dimethylmethylene blue (DMB)
assay. To assess nitric oxide production, we measured the con-
centration of total nitrate and nitrite (termed “NOx”) in the media
using the Griess reaction assay. Results were divided by the wet
weight of the explant and normalized to the average control con-
dition value per joint (i.e., 0 ng/ml leptin and no treatment). Each
dose and treatment condition represents the average of 3-4 joints
and 4-5 explants per joint. Statistical signiﬁcance for treatment
effects at 0 ng/ml leptin were determined with student’s t-test.
Signiﬁcant leptin dose effects were determined using a single
factor ANOVA, with Dunnett’s post-hoc test.
Results: Leptin had no independent effect on S-GAG release
or NOx production in articular cartilage explants (p>0.05). FA
treatment increased S-GAG release by 70%, which was negated
by 10 and 100 ng/ml of leptin (Fig. 1A). IL-1 increased S-GAG
release by 3.8-fold, which was further increased to approximately
7-fold with leptin doses of 1, 10, or 100 ng/ml (Fig. 1A). When FA
and IL-1 treatments were combined, S-GAG release increased
markedly by 13.4-fold above the control value (Fig. 1A). FA
treatment had no effect on NOx production, although when
combined with IL-1, it decreased NOx production compared to
IL-1 alone (58-fold vs 80-fold, respectively) (Fig. 1B). Leptin did
not signiﬁcantly affect IL-1 or IL-1 + FA induced NOx production
(Fig. 1B).
Figure 1. Open symbols are control values. *p<0.05 versus control. #p<0.05
versus smaller leptin dose. Values = mean ± SEM.
Conclusions: Palmitic and oleic FA, when combined with IL-1,
have a signiﬁcant synergistic effect on S-GAG release, more
than doubling the independent combined effects of FA and IL-1.
Leptin also acted synergistically with IL-1 to increase S-GAG
release, consistent with previously reported pro-inﬂammatory
effects of leptin on chondrocyte activity, although our results
were independent of nitric oxide production. Surprisingly, though,
leptin reduced FA-induced S-GAG release, suggesting that leptin
is protective against the catabolic effects of a high-FA load.
Leptin may attenuate FA-induced catabolism by stimulating FA
oxidation and reducing intra-cellular FA levels.
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PGE2 ATTENUATES AGGRECAN GENE EXPRESSION
AND ACCELERATES AGGRECAN DEGRADATION VIA
ACTIVATION OF ADAMTS IN OA CHONDROCYTES
M. Attur, M. Dave, J. Patel, H. Al-Mussawir, G. Palmer,
M. Pillinger, S.B. Abramson
NYU-Hospital for Joint Diseases, New York, NY
Purpose: OA cartilage explants spontaneously produce PGE2,
the predominant eicosanoid of cyclooxygenase pathway, which
signals via four G-protein-coupled receptors, EP1-EP4. The
present study investigates the role of PGE2 on aggrecan
metabolism in chondrocytes.
Methods: OA chondrocytes were isolated from patients under-
going knee replacement surgery. Proteoglycan synthesis was de-
termined using 35S incorporation. MMP-13, cytokines were es-
timated using ELISA kits (R&D systems). Induction of ADAMTS
was determined using TaqMan real time PCR and fold change
was calculated and normalized with GAPDH using 2 delta Ct
method.
Results: The expression of prostaglandin biosynthetic pathway
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enzymes, COX-1, COX-2, cPGES and mPGES was demon-
strated in OA cartilage by positive immunostaining. IL-1 sig-
niﬁcantly augmented expression of COX-2 and mPGES in OA
cartilage. Treatment of OA cartilage/chondrocytes with PGE2
(0.1-10uM) resulted in the following dose dependent catabolic
effects with respect to aggrecan metabolism 1) inhibition of pro-
teoglycan synthesis (35S incorporation) by chondrocyte cultures
to levels of 75% of control (p<0.01), 2) augmentation of release
of aggrecan fragment CS846 epitope, 3) inhibition of aggrecan
gene expression and 4) induction of production of pro-MMP-13,
IL-6 and IL-8. The potency of PGE2 effects on PG synthesis
were comparable to that of IL-1b, and the inhibitory effects of
the combination of IL-1 and PGE2 (10uM) were additive. PGE2
augmentation of collagen degradation (C12C assay) could be
blocked by MMP inhibitor, Ilomastat (5uM) (p<0.05) in OA car-
tilage explant cultures. In OA chondrocytes, PGE2 inhibition by
celecoxib (2uM) treatment partially reversed IL-1 mediated in-
hibition of PG synthesis from 45% to 65% of control values
(p<0.01). Similarly, IL-1 mediated induction of aggrecanase 4
and 5 (ADAMTS) was also reversed by celecoxib treatment by
more than 60%. Interestingly, blocking of EP4 receptor, a known
receptor of PGE2, with EP4 antagonist (A23858) mimicked cele-
coxib, and inhibited ADAMTS 4 and 5 expressions as analyzed
by real time PCR.
Conclusions: Our results suggest that IL-1 mediated inhibition
of proteoglycan aggrecan expression and enhanced degradation
is, in part, mediated by prostaglandin E2 acting via the EP4
receptor.These ﬁndings underscore the importance of PGE2 as
a central mediator of OA pathogenesis.
172
ANTI-CATABOLIC EFFECT OF FIBROBLAST GROWTH
FACTOR-2 IN HUMAN ARTICULAR CARTILAGE
Y. Sawaji, J. Saklatvala
Imperial College, London, United Kingdom
Purpose: Articular chondrocytes are surrounded by an extra-
cellular pool of ﬁbroblast growth factor (FGF)-2. The roles of
FGF-2 on aggrecan catabolism by aggrecanases; a disintegrin
and metalloproteinase with thrombospondin motifs (ADAMTS)-4
and -5 were investigated in human articular cartilage.
Methods: Normal human articular cartilages were stimulated
with IL-1α in the presence or absence of FGF-2. Aggrecan
catabolism was assessed by measuring the release of gly-
cosaminoglycan by DMMB and assayed by western blotting
with neo-epitope antibodies (ARGS and AGEG) which recog-
nize aggrecanase dependent aggrecan fragments. The expres-
sion of ADAMTS-4 and -5 were measured by RT-PCR. Matrix
metalloproteinase (MMP)-1, -3 and -13 and tissue inhibitor of
metalloproteinases (TIMP)-1 and 3 production was measured
by western blotting. Interleukin (IL)-6 and -8 were measured by
ELISA. Proteoglycan synthesis was monitored by incorporation
of 35S labelled sulphate incorporation.
Results: IL-1α caused cleavage of aggrecan in cultured human
articular cartilage explants, with release of aggrecan fragments
containing ARGS and AGEG neo-epitopes. These were inhibited
by exogenous FGF-2 (1-100 ng/ml). TNFα and retinoic acid also
stimulated release of neo-epitope bearing fragments and this was
also suppressed by FGF-2. IL-1α induced mRNA for ADAMTS-4
and ADAMTS-5 in cartilage explants and isolated chondrocytes.
FGF-2 inhibited the IL-1α-induced increase in both ADAMTS-
4 and ADAMTS-5 mRNA. IL-1α-induced aggrecan degradation
was inhibited by exogenous TIMP-1 as well as N-terminal TIMP-
3, although FGF-2 did not affect their production when IL-1α was
present. FGF-2 did not prevent IL-1α suppression of proteoglycan
synthesis nor its ability to stimulate the production of IL-6, -8,
MMP-1, -3 and -13.
Conclusions: Our ﬁndings suggest that FGF-2 may play a
chondroprotective role in human articular cartilage by controlling
the expression of the aggrecanase, ADAMTS-4 and ADAMTS-5.
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ACTIVATION OF p38α AND p38γ BY IL-1 AND INHIBITION
BY IGF-I AND OP-1
D. Long, R.F. Loeser Jr.
Wake Forest Universtiy, Winston Salem, NC
Purpose: IGF-I and OP-1 have been shown to inhibit IL-1β stim-
ulation of chondrocyte MMP expression. IL-1 signaling requires
activation of the p38 MAP kinase. Four different isoforms of p38
have been previously described (alpha, beta, gamma, and delta)
but their function has not been deﬁned in chondrocytes. The
aim of this study was to determine which p38 isoforms mediate
chondrocyte IL-1 signaling and determine if they are inhibited by
the growth factor combination of IGF-I and OP-1.
Methods: Human articular chondrocytes were isolated by enzy-
matic digestion of normal cartilage obtained from tissue donors
and OA cartilage removed during joint replacement. Cells were
cultured in DMEM/F12 with 10% serum to conﬂuency and them
made serum-free for stimulation studies. Speciﬁc p38 isoform
expression was detected by Western blotting of protein lysates
using p38 isoform speciﬁc antibodies and RT-PCR of RNA prepa-
rations using p38 isoform speciﬁc primers. Cytosol and nuclear
preparations were made using a commercially available kit to
detect p38 translocation to the nucleus after cytokine stimulation.
Results: RT-PCR and Western blotting showed that p38α and
p38γ were the most highly expressed p38 isoforms in chondro-
cytes. Western Blotting using a phospho-speciﬁc p38 antibody
(that recognizes all four p38 isoforms) after IL-1 stimulation
of chondrocytes revealed the presence of two bands. Based
on molecular weight and previous studies, we conﬁrmed that
one band was p38α. We used 2-D gel electrophoresis to also
conﬁrm that IL-1 stimulated phosphorylation of p38γ. Translo-
cation experiments revealed a shift of phosphorylated p38 to
the nucleus after IL-1 stimulation. This phosphorylated p38 was
determined to be p38α, as this isoform was shown to be present
in the nucleus whereas p38γ could not be detected in the nu-
clear preparations. The combination of IGF-1 and OP-1, added
30 minutes prior to IL-1 stimulation, inhibited IL-1 induced p38
phosphorylation as well as IL-1 induced phosphorylation of ATF-
2 and MAPKAPK-2, two signaling molecules directly downstream
of p38α but not p38γ.
Conclusions: These results are, to our knowledge, the ﬁrst
to demonstrate IL-1 phosphorylation of two p38 isoforms (al-
pha and gamma) in chondrocytes. Although phosphorylation of
both isoforms was stimulated by IL-1 and phosphorylation of
p38α was inhibited by IGF-I+OP-1, it appeared that p38α me-
diates its effects at the level of gene transcription. p38α but
not p38γ was found to translocate to the nucleus and the p38α
substrates ATF-2 and MAPKAPK-2 were both phosphorylated.
Further experiments are needed to determine the role of p38γ in
chondrocyte signaling.
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JNK2 SULFENIC ACID FORMATION IN THE REDOX
REGULATION OF α5β1 INTEGRIN SIGNALING
E.A. Erickson, C.M. Furdui, A.W. Tsang, J.S. Fetrow,
L.B. Poole, R.F. Loeser
Wake Forest University, Winston Salem, NC
Purpose: Reactive oxygen species (ROS) act as secondary
messengers in signaling cascades activated in response to extra-
